These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32615462)

  • 1. The effect of baclofen on objective and subjective sleep measures in a model of transient insomnia.
    Raad S; Wilkerson M; Jones KR; Orr WC
    Sleep Med; 2020 Aug; 72():130-134. PubMed ID: 32615462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of SM-1 in a transient insomnia model.
    Dahl T; Chen LB; Zammit G; Ahmad M; Roth T
    Hum Psychopharmacol; 2019 Nov; 34(6):e2713. PubMed ID: 31837050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials.
    Huang Z; Zhan S; Chen C; Zhang R; Zhou Y; He J; Lin Z; Bao C; Zhu S; Zhao J; Zhang S; Jiang Y; Wang Y
    Sleep; 2024 Feb; 47(2):. PubMed ID: 37875349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How well can a large number of polysomnography sleep measures predict subjective sleep quality in insomnia patients?
    Svetnik V; Snyder ES; Tao P; Roth T; Lines C; Herring WJ
    Sleep Med; 2020 Mar; 67():137-146. PubMed ID: 31926466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
    Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
    Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y
    Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
    Staner C; Joly F; Jacquot N; Vlasova ID; Nehlin M; Lundqvist T; Edenius C; Staner L
    Curr Med Res Opin; 2010 Jun; 26(6):1423-31. PubMed ID: 20397964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
    Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.
    Ivgy-May N; Ruwe F; Krystal A; Roth T
    Sleep Med; 2015 Jul; 16(7):838-44. PubMed ID: 26047892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
    Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
    Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
    J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.
    Ivgy-May N; Roth T; Ruwe F; Walsh J
    Sleep Med; 2015 Jul; 16(7):831-7. PubMed ID: 26047890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia.
    Walsh JK; Deacon S; Dijk DJ; Lundahl J
    Sleep; 2007 May; 30(5):593-602. PubMed ID: 17552374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study.
    Roth T; Wright KP; Walsh J
    Sleep; 2006 Mar; 29(3):335-41. PubMed ID: 16553019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.
    Scharf M; Rogowski R; Hull S; Cohn M; Mayleben D; Feldman N; Ereshefsky L; Lankford A; Roth T
    J Clin Psychiatry; 2008 Oct; 69(10):1557-64. PubMed ID: 19192438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.